Traina T - Search Results

1

Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancer.

Conlin AK, Seidman AD, Bach A, Lake D, Dickler M, D'Andrea G, Traina T, Danso M, Brufsky AM, Saleh M, Clawson A, Hudis CA. Conlin AK, et al. Among authors: traina t. Clin Breast Cancer. 2010 Aug 1;10(4):281-7. doi: 10.3816/CBC.2010.n.036. Clin Breast Cancer. 2010. PMID: 20705560 Free PMC article. Clinical Trial.

2

Aromatase inhibitors for hormonal therapy of early-stage breast cancer.

Traina TA, Dickler MN. Traina TA, et al. Curr Opin Investig Drugs. 2004 Jun;5(6):605-10. Curr Opin Investig Drugs. 2004. PMID: 15242248 Review.

3

Weekly topotecan for recurrent endometrial cancer: a case series and review of the literature.

Traina TA, Sabbatini P, Aghajanian C, Dupont J. Traina TA, et al. Gynecol Oncol. 2004 Oct;95(1):235-41. doi: 10.1016/j.ygyno.2004.07.035. Gynecol Oncol. 2004. PMID: 15385138 Review.

4

Nasal septum perforation in a bevacizumab-treated patient with metastatic breast cancer.

Traina TA, Norton L, Drucker K, Singh B. Traina TA, et al. Oncologist. 2006 Nov-Dec;11(10):1070-1. doi: 10.1634/theoncologist.11-10-1070. Oncologist. 2006. PMID: 17110625 Free article. No abstract available.

5

Bevacizumab for advanced breast cancer.

Traina TA, Rugo HS, Dickler M. Traina TA, et al. Hematol Oncol Clin North Am. 2007 Apr;21(2):303-19. doi: 10.1016/j.hoc.2007.03.006. Hematol Oncol Clin North Am. 2007. PMID: 17512451 Review.

6

Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer.

Traina TA, Poggesi I, Robson M, Asnis A, Duncan BA, Heerdt A, Dang C, Lake D, Moasser M, Panageas K, Borgen P, Norton L, Hudis C, Dickler MN. Traina TA, et al. Breast Cancer Res Treat. 2008 Sep;111(2):377-88. doi: 10.1007/s10549-007-9787-1. Epub 2007 Oct 20. Breast Cancer Res Treat. 2008. PMID: 17952589 Clinical Trial.

7

Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancer.

Traina TA, Theodoulou M, Feigin K, Patil S, Tan KL, Edwards C, Dugan U, Norton L, Hudis C. Traina TA, et al. J Clin Oncol. 2008 Apr 10;26(11):1797-802. doi: 10.1200/JCO.2007.13.8388. J Clin Oncol. 2008. PMID: 18398145 Clinical Trial.

8

Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer.

Gonzalez-Angulo AM, Stemke-Hale K, Palla SL, Carey M, Agarwal R, Meric-Berstam F, Traina TA, Hudis C, Hortobagyi GN, Gerald WL, Mills GB, Hennessy BT. Gonzalez-Angulo AM, et al. Among authors: traina ta. Clin Cancer Res. 2009 Apr 1;15(7):2472-8. doi: 10.1158/1078-0432.CCR-08-1763. Epub 2009 Mar 10. Clin Cancer Res. 2009. PMID: 19276248

9

Bevacizumab in the treatment of metastatic breast cancer.

Traina TA. Traina TA. Oncology (Williston Park). 2009 Apr 15;23(4):327-32. Oncology (Williston Park). 2009. PMID: 19476261 Free article. Review.

10

PIK3CA mutation associates with improved outcome in breast cancer.

Kalinsky K, Jacks LM, Heguy A, Patil S, Drobnjak M, Bhanot UK, Hedvat CV, Traina TA, Solit D, Gerald W, Moynahan ME. Kalinsky K, et al. Clin Cancer Res. 2009 Aug 15;15(16):5049-59. doi: 10.1158/1078-0432.CCR-09-0632. Epub 2009 Aug 11. Clin Cancer Res. 2009. PMID: 19671852

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters